Goodwin Science Advisor, Yoko J. Bian Ph.D., from New York, practices in Patent Litigation, Artificial Intelligence and Machine Learning, Litigation, and more.

Yoko J. Bian, Ph.D.

Science AdvisorIP Litigation
Spoken Languages
French German Arabic
Yoko J. Bian, Ph.D.
New York
+1 212 813 8836

Yoko Bian is a science advisor in the firm’s Litigation department and a member of its Intellectual Property practice. She contributes to the firm’s work in patent litigation, patent opinions, and due diligence. Yoko has worked on cases and matters including complex technologies including web-based software, 3D printing, OLED and LCD displays, telematics, and orthopaedic devices.

Professional Experience

Yoko has been involved in various stages of patent and trade secret litigation in district courts and at the United States International Trade Commission (ITC).

Prior to joining Goodwin, Yoko obtained her Ph.D. in Nanotechnology and Materials Science. Her doctoral research was an in silico study using quantum mechanics and semi-empirical methods to design proton-conductive, histidine-based biomimetic nanostructures.

Professional Activities

Yoko is a member of the Asian American Bar Association of New York (AABANY), the American Chemical Society (ACS), and the American Society for Enology and Viticulture (ASEV).

She serves on the ACS Committee on Finance, is an active member of the ChIPs Network, and leads 500 Women Scientists NYC as co-president.

Credentials

Education

PhDNanotechnology and Materials Science2022

The Graduate Center, City University of New York


BSEconomics and Finance2016

Centre College

BSChemistry2016

Centre College

Admissions

Bars

  • U.S. Patent and Trademark Office (USPTO)

Recognition & Awards

Yoko is a member of Omicron Delta Epsilon (ODE) and Omicron Delta Kappa (ODK).

Yoko is also a member of G20 Young Entrepreneurs’ Alliance.

Publications

Yoko has published scientific articles in peer-reviewed journals, including Int. J. Quantum Chem and J. Am. Chem. Soc. She has presented her research at international conferences, including American Chemical Society meetings, where she has also spoken on litigation finance and intellectual property issues.

She is a contributor of Big Molecule Watch, Goodwin’s blog covering legal, business and regulatory developments involving biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA).

  • Speaker, “Litigation Financing Demystified: Insights from Funders and Counsel,” Webinar, December 14, 2023
  • Speaker, “An Overview of the Biosimilars Market in China,” Webinar, January 1, 2024
  • Speaker, “Perspectives on Litigation Financing in Patent Litigation: Empowering Claimants and Enhancing Risk Management,” American Chemical Society Spring Conference 2024, March 17, 2024
  • Author, “Commentary: What Law Finance Group Looks for in a Litigant,” Law.com, November 14, 2023
  • Speaker, “Role of the Chemist as an Expert Witness in Pharmaceutical Patent Litigation,” American Chemical Society Fall Conference 2023: Harnessing the Power of Data, August 14, 2023